BE718183A - - Google Patents

Info

Publication number
BE718183A
BE718183A BE718183DA BE718183A BE 718183 A BE718183 A BE 718183A BE 718183D A BE718183D A BE 718183DA BE 718183 A BE718183 A BE 718183A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE718183A publication Critical patent/BE718183A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/38Silver; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BE718183D 1967-07-17 1968-07-17 BE718183A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65383067A 1967-07-17 1967-07-17

Publications (1)

Publication Number Publication Date
BE718183A true BE718183A (enrdf_load_stackoverflow) 1969-01-17

Family

ID=24622450

Family Applications (1)

Application Number Title Priority Date Filing Date
BE718183D BE718183A (enrdf_load_stackoverflow) 1967-07-17 1968-07-17

Country Status (8)

Country Link
BE (1) BE718183A (enrdf_load_stackoverflow)
DE (1) DE1792053B1 (enrdf_load_stackoverflow)
ES (1) ES356142A1 (enrdf_load_stackoverflow)
FR (2) FR1586125A (enrdf_load_stackoverflow)
GB (2) GB1240545A (enrdf_load_stackoverflow)
IE (1) IE32197B1 (enrdf_load_stackoverflow)
NL (1) NL6809794A (enrdf_load_stackoverflow)
PH (1) PH10639A (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049802A (en) 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
DE2804931A1 (de) * 1978-02-06 1979-08-16 Fresenius Chem Pharm Ind Metallsulfadiazine in feinteiliger form
US4384117A (en) * 1980-03-18 1983-05-17 The United States Of America As Represented By The Secretary Of The Army Silver metachloridine
AU1388388A (en) * 1987-04-01 1988-10-06 Dak-Laboratoriet A/S Benzoic acid derivatives and use thereof
CA2024220A1 (en) * 1990-08-29 1992-03-01 Don Simmons Composition containing silver sulfadiazine and benzocaine for use in the treatment of wounds following laser surgery
IT1243435B (it) * 1990-10-05 1994-06-10 Altergon Sa Composizioni farmaceutiche per uso topico comprendenti acido ialuronico sale sodico e sostanze disinfettanti
US7074788B2 (en) 2001-11-22 2006-07-11 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EP1631558A1 (en) * 2003-05-21 2006-03-08 Biovitrum Ab Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i
US7173030B2 (en) 2003-05-21 2007-02-06 Biovitrum Ab Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
SE0301884D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use III
SE0301888D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use VII
SE0301882D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use I
SE0301886D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use V
WO2004113310A1 (en) * 2003-06-25 2004-12-29 Biovitrum Ab Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
SE0301885D0 (sv) * 2003-06-25 2003-06-25 Biovitrum Ab New use IV
BRPI1104620B1 (pt) * 2011-09-09 2020-04-07 Lucia Teixeira De Carvalho composição farmacêutica para tratamento de queimaduras e lesões da pele e seu processo de preparação

Also Published As

Publication number Publication date
FR1586125A (enrdf_load_stackoverflow) 1970-02-13
FR8146M (enrdf_load_stackoverflow) 1970-08-17
PH10639A (en) 1977-07-22
NL6809794A (enrdf_load_stackoverflow) 1969-01-21
IE32197L (en) 1969-01-17
IE32197B1 (en) 1973-05-16
GB1240545A (en) 1971-07-28
DE1792053B1 (de) 1971-07-29
GB1240546A (en) 1971-07-28
ES356142A1 (es) 1970-02-16

Similar Documents

Publication Publication Date Title
AU425114B2 (enrdf_load_stackoverflow)
AT298283B (enrdf_load_stackoverflow)
AU416737B2 (enrdf_load_stackoverflow)
AU2277767A (enrdf_load_stackoverflow)
AU342066A (enrdf_load_stackoverflow)
AU610966A (enrdf_load_stackoverflow)
AU1273466A (enrdf_load_stackoverflow)
AU2116667A (enrdf_load_stackoverflow)
AU2256867A (enrdf_load_stackoverflow)
AU3189468A (enrdf_load_stackoverflow)
AU2454867A (enrdf_load_stackoverflow)
AU3151267A (enrdf_load_stackoverflow)
AU2528767A (enrdf_load_stackoverflow)
AU2977667A (enrdf_load_stackoverflow)
BE509738A (enrdf_load_stackoverflow)
BE514578A (enrdf_load_stackoverflow)
AU1868267A (enrdf_load_stackoverflow)
AU1763766A (enrdf_load_stackoverflow)
AU34866A (enrdf_load_stackoverflow)
AU408412B2 (enrdf_load_stackoverflow)
AU1677166A (enrdf_load_stackoverflow)
AU1614766A (enrdf_load_stackoverflow)
AU459699A (enrdf_load_stackoverflow)
BE692779A (enrdf_load_stackoverflow)
BE692199A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: RESEARCH CORP.

Effective date: 19880717